Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esflurbiprofen patch vs celecoxib tablet after total knee arthroplasty
TCTR20250625003Phase 4Recruiting
- Sponsor
- Department of Orthopaedics, Faculty of Medicine, Chulalongkorn University
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esflurbiprofen, celecoxib in postoperative pain, sponsored by Department of Orthopaedics, Faculty of Medicine, Chulalongkorn University. Started Oct 2024; status: recruiting.
02
Drugs
esflurbiprofencelecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on TCTR20250625003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250625003.